• GSK reported profit attributable to shareholders of GBP 3.72 billion for the nine months ended September 30, 2026.
• Turnover totaled GBP 24.93 billion, including GBP 10.89 billion from Specialty Medicines.
• Vaccines turnover reached GBP 7.02 billion, while General Medicines contributed GBP 7.02 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GSK plc published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.